UTHR   $351.7  2.76% Market Closed After Close 351.33 -0.11%

United Therapeutics Corp
Total Cash 2.97B
totalCashPerShare 66.789
EBITDA 1.33B
Total Debt 500.00M
quickRatio 3.974
currentRatio 4.349
Total Revenue 2.62B
debtToEquity 8.776
Revenue/Share 56.455
ROA 0.117910005
ROE 0.19253999
grossProfits
freeCashflow 649.90M
operatingCashflow 1.11B
earningsGrowth 0.12
revenueGrowth 0.198
grossMargins 0.88848996
ebitdaMargins 0.5064
operatingMargins 0.44748002
profitMargins 0.40868
enterpriseValue 12.62B
forwardPE 12.444771
floatShares 40.80M
sharesOutstanding 44.49M
sharesShort 4.09M
sharesShortPriorMonth 4.12M
dateShortInterest
sharesPercentSharesOut 0.09%
heldPercentInsiders 0.02%
heldPercentInstitutions 1.06%
Short Ratio help_outline 7.92%
shortPercentOfFloat 0.12%
impliedSharesOutstanding
bookValue 128.253
Price To Book help_outline 2.64
earningsQuarterlyGrowth 0.07
netIncomeToCommon 1.07B
trailingEps 21.77%
forwardEps 27.25%
enterpriseToEbitda 9.52
lastDividendValue
lastDividendDate
currentQuarterEstimate 6.42 3Q 2024
institutionsCount 837
lastUpdated Sept. 16, 2024, 11:28 a.m.